101
Participants
Start Date
September 24, 2019
Primary Completion Date
December 20, 2019
Study Completion Date
December 30, 2020
Cytosponge™
The device consists of a spherical mesh enclosed in a gelatine capsule and attached to a string. The capsule is swallowed and allowed to reach the stomach . In the stomach the capsule is left for up to 5 minutes where it dissolves allowing the sponge to expand to its full size. It is then withdrawn using the suture, and as it does so collects cells from the lining of the oesophagus.
Majengo Unit, Kilimanjaro Clinical Research Institute, Moshi
Collaborators (1)
Kilimanjaro Clinical Research Institute
OTHER
University of Cambridge
OTHER
International Agency for Research on Cancer
OTHER